Sputnik V vaccine

Dr Reddy's gets DCGI nod to conduct phase 2/3 human trails of Russian COVID vaccine Sputnik V

The Hyderabad-based drug maker said in a press release that this will bea multi-center and randomised controlled study, which willinclude safety and immunogenicity study.

published on : 17th October 2020
IPL_2020